DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia

Fourteen novel ATM mutations

Monia Magliozzi, Maria Piane, Isabella Torrente, Lorenzo Sinibaldi, Giovanni Rizzo, Camilla Savio, Patrizia Lulli, Alessandro De Luca, Bruno Dallapiccola, Luciana Chessa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The gene for ataxia-telangiectasia (A-T:MIM: #208900), ATM, spans about 150~kb of genomic DNA and is composed of 62 coding exons. ATM mutations are found along the entire coding sequence of the gene, without evidence of mutational hot spots. Using DNA as the starting material, we used denaturing high performance liquid chromatography (DHPLC) technique to search for ATM gene mutations. Initially, DHPLC was validated in a retrospective study of 16 positive control samples that included 19 known mutations; 100% of mutations were detected. Subsequently, DHPLC was used to screen for mutations a cohort of 22 patients with the classical form of A-T. A total of 27 different mutations were identified on 38 of the 44 alleles, corresponding to a 86% detection rate. Fourteen of the mutations were novel. In addition, 15 different variants and polymorphisms of unknown functional significance were found. The high incidence of new and individual A-T mutations in our cohort of patients demonstrates marked mutational heterogeneity of A-T in Italy and corroborate the efficiency of DHPLC as a method for the mutation screening of A-T patients.

Original languageEnglish
Pages (from-to)257-264
Number of pages8
JournalDisease Markers
Volume22
Issue number4
Publication statusPublished - 2006

Fingerprint

Ataxia Telangiectasia
High performance liquid chromatography
Automatic teller machines
Screening
Genes
High Pressure Liquid Chromatography
Mutation
DNA
Polymorphism
Exons
Italy
Retrospective Studies
Alleles

Keywords

  • Ataxia-Telangiectasia
  • ATM
  • DHPLC
  • Mutations
  • Polymorphisms

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry

Cite this

Magliozzi, M., Piane, M., Torrente, I., Sinibaldi, L., Rizzo, G., Savio, C., ... Chessa, L. (2006). DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia: Fourteen novel ATM mutations. Disease Markers, 22(4), 257-264.

DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia : Fourteen novel ATM mutations. / Magliozzi, Monia; Piane, Maria; Torrente, Isabella; Sinibaldi, Lorenzo; Rizzo, Giovanni; Savio, Camilla; Lulli, Patrizia; De Luca, Alessandro; Dallapiccola, Bruno; Chessa, Luciana.

In: Disease Markers, Vol. 22, No. 4, 2006, p. 257-264.

Research output: Contribution to journalArticle

Magliozzi, M, Piane, M, Torrente, I, Sinibaldi, L, Rizzo, G, Savio, C, Lulli, P, De Luca, A, Dallapiccola, B & Chessa, L 2006, 'DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia: Fourteen novel ATM mutations', Disease Markers, vol. 22, no. 4, pp. 257-264.
Magliozzi M, Piane M, Torrente I, Sinibaldi L, Rizzo G, Savio C et al. DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia: Fourteen novel ATM mutations. Disease Markers. 2006;22(4):257-264.
Magliozzi, Monia ; Piane, Maria ; Torrente, Isabella ; Sinibaldi, Lorenzo ; Rizzo, Giovanni ; Savio, Camilla ; Lulli, Patrizia ; De Luca, Alessandro ; Dallapiccola, Bruno ; Chessa, Luciana. / DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia : Fourteen novel ATM mutations. In: Disease Markers. 2006 ; Vol. 22, No. 4. pp. 257-264.
@article{58decd2926154d32bba518a6c109b36c,
title = "DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia: Fourteen novel ATM mutations",
abstract = "The gene for ataxia-telangiectasia (A-T:MIM: #208900), ATM, spans about 150~kb of genomic DNA and is composed of 62 coding exons. ATM mutations are found along the entire coding sequence of the gene, without evidence of mutational hot spots. Using DNA as the starting material, we used denaturing high performance liquid chromatography (DHPLC) technique to search for ATM gene mutations. Initially, DHPLC was validated in a retrospective study of 16 positive control samples that included 19 known mutations; 100{\%} of mutations were detected. Subsequently, DHPLC was used to screen for mutations a cohort of 22 patients with the classical form of A-T. A total of 27 different mutations were identified on 38 of the 44 alleles, corresponding to a 86{\%} detection rate. Fourteen of the mutations were novel. In addition, 15 different variants and polymorphisms of unknown functional significance were found. The high incidence of new and individual A-T mutations in our cohort of patients demonstrates marked mutational heterogeneity of A-T in Italy and corroborate the efficiency of DHPLC as a method for the mutation screening of A-T patients.",
keywords = "Ataxia-Telangiectasia, ATM, DHPLC, Mutations, Polymorphisms",
author = "Monia Magliozzi and Maria Piane and Isabella Torrente and Lorenzo Sinibaldi and Giovanni Rizzo and Camilla Savio and Patrizia Lulli and {De Luca}, Alessandro and Bruno Dallapiccola and Luciana Chessa",
year = "2006",
language = "English",
volume = "22",
pages = "257--264",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia

T2 - Fourteen novel ATM mutations

AU - Magliozzi, Monia

AU - Piane, Maria

AU - Torrente, Isabella

AU - Sinibaldi, Lorenzo

AU - Rizzo, Giovanni

AU - Savio, Camilla

AU - Lulli, Patrizia

AU - De Luca, Alessandro

AU - Dallapiccola, Bruno

AU - Chessa, Luciana

PY - 2006

Y1 - 2006

N2 - The gene for ataxia-telangiectasia (A-T:MIM: #208900), ATM, spans about 150~kb of genomic DNA and is composed of 62 coding exons. ATM mutations are found along the entire coding sequence of the gene, without evidence of mutational hot spots. Using DNA as the starting material, we used denaturing high performance liquid chromatography (DHPLC) technique to search for ATM gene mutations. Initially, DHPLC was validated in a retrospective study of 16 positive control samples that included 19 known mutations; 100% of mutations were detected. Subsequently, DHPLC was used to screen for mutations a cohort of 22 patients with the classical form of A-T. A total of 27 different mutations were identified on 38 of the 44 alleles, corresponding to a 86% detection rate. Fourteen of the mutations were novel. In addition, 15 different variants and polymorphisms of unknown functional significance were found. The high incidence of new and individual A-T mutations in our cohort of patients demonstrates marked mutational heterogeneity of A-T in Italy and corroborate the efficiency of DHPLC as a method for the mutation screening of A-T patients.

AB - The gene for ataxia-telangiectasia (A-T:MIM: #208900), ATM, spans about 150~kb of genomic DNA and is composed of 62 coding exons. ATM mutations are found along the entire coding sequence of the gene, without evidence of mutational hot spots. Using DNA as the starting material, we used denaturing high performance liquid chromatography (DHPLC) technique to search for ATM gene mutations. Initially, DHPLC was validated in a retrospective study of 16 positive control samples that included 19 known mutations; 100% of mutations were detected. Subsequently, DHPLC was used to screen for mutations a cohort of 22 patients with the classical form of A-T. A total of 27 different mutations were identified on 38 of the 44 alleles, corresponding to a 86% detection rate. Fourteen of the mutations were novel. In addition, 15 different variants and polymorphisms of unknown functional significance were found. The high incidence of new and individual A-T mutations in our cohort of patients demonstrates marked mutational heterogeneity of A-T in Italy and corroborate the efficiency of DHPLC as a method for the mutation screening of A-T patients.

KW - Ataxia-Telangiectasia

KW - ATM

KW - DHPLC

KW - Mutations

KW - Polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=33751086771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751086771&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 257

EP - 264

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

IS - 4

ER -